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Abstract.  Transgenesis constitutes an important tool for pharmacological protein production and livestock
improvement.  We evaluated the potential of laparoscopic insemination (LI), in vitro fertilization (IVF) and
intracytoplasmic sperm injection (ICSI) to produce egfp-expressing ovine embryos, using spermatozoa previously
exposed to pCX-EGFP plasmid in two different sperm/DNA incubation treatments: “Long Incubation” (2 h at 17 C) and
“Short Incubation” (5 min at 5 C).  For LI, Merino sheep were superovulated and inseminated with treated fresh semen
from Merino rams.  The embryos were recovered by flushing the uterine horns.  For IVF and ICSI, slaughterhouse
oocytes were fertilized with DNA-treated frozen/thawed sperm.  All recovered embryos were exposed to blue light
(488 nm) to determine green fluorescent morulae and blastocysts rates.  High cleavage and morulae/blastocysts rates
accompanied the LI and IVF procedures, but no egfp-expressing embryos resulted.  In contrast, regardless of the sperm/
plasmid incubation treatment, egfp-expressing morulae and blastocysts were always obtained by ICSI, and the highest
transgenesis rate (91.6%) was achieved with Short Incubation.  In addition, following the incubation of labeled plasmid
DNA, after Long or Short exposure treatments, with fresh or frozen/thawed spermatozoa, only non-motile fresh
spermatozoa could maintain an attached plasmid after washing procedures.  No amplification product could be
detected following PCR treatment of LI embryos whose zonae pellucidae (ZP) had been removed.  In order to establish
conditions for transgenic ICSI in the ovine, we compared three different activation treatments, and over 60% of the
obtained blastocysts expressed the transgene.  For ICSI embryos, FISH analysis found possible signals compatible with
integration events.  In conclusion, our results show that in the ovine, under the conditions studied, ICSI is the only
method capable of producing exogenous gene-expressing embryos using spermatozoa as vectors.
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ransgenesis in mammals constitutes an important tool for
recombinant protein production [1, 2] and also for livestock
improvement [3].  Currently, the challenge is to find a high effi-
ciency and low-cost technique for producing transgenic animals.
Microinjection of foreign DNA into the male pronuclei of zygotes
[4] and nuclear transfer using genetically modified somatic donor
cells [5], are two commonly used methods for the generation of
transgenic animals.  Transgenesis by microinjection is used in mice
mainly for research purposes.  This procedure has also proven to be
efficient in rabbits, sheep and pigs [6], but it is quite dependant on
proper visualization of the male pronucleus.  In addition, nuclear
transfer, using genetically modified somatic donor cells is not very
efficient, which can be partly explained by epigenetic reprogram-
ming failure [7].
Evidence of heterologous DNA interaction with mammalian
spermatozoa and subsequent delivery into the oocyte during fertili-
zation was first reported in 1971 [8].  Sperm-mediated gene
transfer has opened the possibility for large-scale transgenic animal
production both for basic research and biotechnological applica-
tions.  Several authors have published alternative procedures to
obtain transgenic embryos and offspring by means of LI [9], IVF
[10] and ICSI [11].  These techniques are collectively called
“sperm-mediated gene transfer” (SMGT).  By LI and IVF, the gen-
eration of transgenic animals could be remarkably simple.
However, results obtained so far in mice and domestic animals
have been inconsistent [10, 12–16].  On the other hand, ICSI has
resulted in the production of transgenic offspring in murine and
porcine species, while Southern Blot and FISH analyses in result-
ant embryos and offspring have proven efficient in demonstrating
successful gene integration [11, 17].  However, for successful
large-scale application of transgenic ICSI to domestic species, it is
critical to solve the ICSI fertilization problem associated with acti-
vation failure [18].
The ovine is a good model in the field of animal transgenesis and
biotechnology due to its relatively short pregnancy period com-
pared with the bovine.  Moreover, its significant saliva and milk
production make the salivary and mammary glands interesting tar-
gets for recombinant protein expression [19].  Nevertheless, to our
knowledge, no work has explored the different variants of SMGT
in the ovine.  The objective of the present study was to produce
exogenous gene-expressing sheep embryos by LI, IVF and ICSI
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techniques using sperm incubated with DNA for a long (2 h to 17
C) or short (5 min to 0–5 C) period of time.  In addition, the inter-
action between sperm and labeled DNA was analyzed by
fluorescent microscopy in order to interpret differences between
treatments.  Presence of exogenous plasmid DNA in LI, IVF and
ICSI embryos was determined by PCR, and localization of exoge-
nous DNA into their nuclei was confirmed by FISH in ICSI-
derived embryos.  Chemical activation following nontransgenic
ICSI has been reported to improve bovine embryo development
[20–24].  We also demonstrated that the activation in transgenic
ICSI improves embryo development [25], showing different out-
comes according to the chemical activation treatments [26].  For
this reason we compared three different activation treatments to
assist the transgenic ICSI technique in the ovine.
Materials and Methods
Animal care and governmental authorization
Animal usage and care treatments were approved by the Institu-
tional Committee of Care and Use of Laboratory Animals of the
Buenos Aires University (Resolution No. 2007/15).  The Secretar-
iat of Agriculture, Livestock, Fisheries and Foods of Argentina, as
counseled by the Comisión Nacional de Biotecnología Argentina
(CONABIA), approved the animal confinement conditions for LI
(Resolution No. 250).
Chemicals and media
Except where otherwise indicated, all chemicals were obtained
from Sigma Chemical (St. Louis, MO, USA).
DNA construction
The plasmid used was pCX-EGFP (kindly provided by Dr M
Okabe, Osaka University, Osaka, Japan) that contains an enhanced
green fluorescent protein gene (egfp) under chimeric cytomegalov-
irus-IE-chicken β-actin enhancer-promoter control [27].  The same
stock of plasmid was used for all the experiments.
Sperm/DNA incubation
Sperm/pCX-EGFP incubation was carried out in accordance
with two procedures 1) In the first procedure, long sperm/DNA
incubation (Long Incubation), fresh or frozen/thawed semen
(pooled from eight rams) was treated as previously described [28],
with slight modifications.  Briefly, collected (Fresh) or thawed
semen straws (Frozen/Thawed) were diluted 1:10 v/v in a pre-
warmed extender SFM [28] (5 ml of fresh semen in 45 ml or 500 μl
of frozen/thawed semen in 4.5 ml).  Seminal plasma (fresh semen)
or cryoprotectant (frozen/thawed semen) were removed by centrif-
ugation at 800 × g in extender medium for 10 min (fresh semen) or
at 495 × g for 5 min (frozen/thawed semen), at room temperature in
both cases.  Then, the supernatant was aspirated, and the sperm
cells were resuspended in the same volume to repeat centrifugation
under the same conditions.  Finally, the spermatozoa were resus-
pended in 2 ml of extender medium at a concentration of 2500 ×106
cells/ml (fresh semen) or in 200 μl of extender medium at a concen-
tration of 100 ×106 cells/ml (frozen/thawed semen) and mixed with
pCX-EGFP plasmid (final concentration: 0.5 μg/million spermato-
zoa).  The spermatozoa and pCX-EGFP plasmid were incubated at
17 C for 2 h.  The flasks were inverted every 20 min to prevent sed-
imentation of sperm 2) In the second procedure, short sperm/DNA
incubation (Short Incubation), sperm/plasmid incubations were
carried out following a previously reported method [11] with slight
modifications.  Briefly, the pooled semen samples (fresh or frozen/
thawed) were diluted and centrifuged as previously described, in
2.8% sodium citrate (F71497) medium containing 100 μM EDTA
(15576-028, Invitrogen).  The spermatozoa were resuspended in 2
ml sodium citrate medium at a concentration of 2500 ×106 cells/ml
(fresh semen) or in 200 μl of sodium citrate medium at a concentra-
tion of 100 ×106 cells/ml (frozen/thawed semen) and incubated
with 0.5 μg of the DNA construct/million spermatozoa (final con-
centration) for 5 min at 5 C (following cooling at a rate of 2 C/3
min).  The same collected Fresh or Frozen/Thawed semen samples
were used for the different treatments.  The semen straws were fro-
zen and thawed by standard procedures.  Both, long and short
sperm/DNA incubation (without previous washing procedures) and
control spermatozoa (without plasmid incubation) were used for
the LI, IVF or ICSI techniques as described below.
Experimental design
Three independent assays were carried out in order to evaluate
exogenous gene-expressing ovine embryo production following the
treatments described above.  For LI, we used fresh sperm subjected
to long or short sperm/DNA incubation to fertilize superovulated
sheep.  For the IVF and ICSI experiments, frozen/thawed sperm
subjected to the same sperm-plasmid incubation treatments were
used to fertilize oocytes collected from slaughterhouse ovaries.  In
order to analyze sperm/exogenous DNA interaction, we tested
labeled-DNA adhesion to sperm membranes after Long and Short
Incubation with fresh and frozen/thawed sperm.  We used PCR and
FISH analyses to determine transgene presence and localization in
these embryos.  Finally, in order to establish conditions for ICSI in
the ovine, this study compared three different activation treatments
to assist the ICSI technique.  Each experiment was replicated at
least three times.
In vivo embryo production
Superovulation treatments:  Donor adult Merino sheep (n=17)
were synchronized by insertion of an intravaginal sponge (60 mg of
medroxyprogesterone acetate, Syntex; Lab.  Syntex, Buenos Aires,
Argentina) for 14 days.  During days 12–14 of treatment, donor
ewes were superovulated with six decreasing doses of FSH i.m.
(18 mg × 2, 14 mg × 2, 8 mg × 2, NIH-FSH-P1, Folltropin®, Bion-
iche, Armidale, NSW, Australia) administered twice a day starting
on the morning of Day 12, 48 h before pessary removal, and finish-
ing 12 h after progestagen withdrawal.  Progestagen removal was
performed on Day 14, coinciding with the fifth FSH treatment, and
a single dose of eCG (200 UI Novormon 5000, Lab. Syntex) was
administered.  All ewes were checked twice daily for the onset of
estrus 24 h after sponge withdrawal using an adult ram. 
Laparoscopic insemination (LI): Ewes in estrus were fasted 12 h
prior to artificial insemination and randomly assigned to LI with
fresh semen from the Long Incubation (n=9), Short Incubation (n=
8) or control (n=1) treatments.  Merino rams (n= 8) of proven fertil-
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ity were utilized as sperm donors.  Ejaculates were collected using
an artificial vagina, pooled in a water bath at 36 C and treated as
described previously.  LI was performed 12 h after estrus detection.
Ewes were placed on a standard cradle for laparoscopic procedures.
The surgical field, cranial to the udder, was shaved and disinfected.
General anesthesia was administered with xylazine (0.5 mg/10 kg
of Kensol 2%, Konig, Buenos Aires, Argentina) and ketamine (25
mg/10 kg of Ketalar; Parke-Davis, Buenos Aires, Argentina) and
local anesthesia was applied (lidocaine, Frankaina 2%; FatroVon-
Frankel, Buenos Aires, Argentina).  Thereafter, an endoscope
(Richard Wolf, Knittlingen, Germany) was inserted into the
abdominal cavity through a trocar approximately 10 cm cranial to
the udder and 5 cm to the left side of the midline for visualization of
the uterine horns.  A second trocar was inserted in the right side of
the abdominal wall and used to deliver 200 μl of previously incu-
bated or not (control) fresh sperm (500 × 106/ewe final
concentration) into the uterine horns (100 μl each) using a cannula
(Aspic for pellet insemination in sheep, 23-gauge needle, IMV;
L’Aigle, France).  Finally, the trocar orifices were treated with a
local antibiotic solution (Young Plata, Quimagro, Buenos Aires,
Argentina), and oxytetracycline (1 ml/10 kg, Hostaciclina LA;
Hoechst, Dublin, Ireland) was given as preventative treatment.
Embryo recovery: Six days after estrus detection, embryos were
collected from donors placed under general anesthesia, as
described above.  In brief, embryos were surgically obtained
through prepubian laparotomy.  Both uterine horns were flushed
using a Foley catheter.  The collection medium was prewarmed (38
C) commercial Complete Flush ViGro (Bioniche, Bogart, GA,
USA).  All the morulae and blastocysts collected from the different
groups were kept separated for examination by fluorescence
microscopy, as described below. 
In vitro embryo production
Oocyte collection and in vitro maturation: Ovaries were col-
lected from slaughterhouses and transported to the laboratory at
ambient temperature.  Cumulus-oocyte-complexes (COCs) were
aspirated with 21-gauge needles from follicles with a diameter of 2
to 5 mm.  They were collected into Dulbecco’s phosphate buffered
saline (DPBS, 14287-072; Gibco, Grand Island, NY, USA) con-
taining 10% fetal bovine serum (FBS, 013/07; Internegocios,
Buenos Aires, Argentina) and 2% antibiotic-antimycotic (ATB,
15240-096; Gibco).  Oocytes covered with at least 3 layers of gran-
ulosa cells were selected for in vitro maturation (IVM) in
bicarbonate-buffered TCM-199 (31100-035; Gibco) containing 2
mM glutamine (G-8540), 10% FBS, 10 μg/ml follicle stimulating
hormone (NIH-FSH-P1, Folltropin®, Bioniche), 0.3 mM sodium
pyruvate (P2256), 100 μM cysteamine (M9768) and 2% ATB.
Oocytes were incubated in 500 μl of medium under mineral oil
(M8410) in 4-well dishes (Nunclon®, Nunc, Naperville, IL, USA)
in an atmosphere of 6.5% CO2 in humidified air at 39 C for 24 h.
In vitro fertilization (IVF): Semen was collected from two
Merino rams using an artificial vagina, and the samples were fro-
zen by standard procedures [29] with Triladyl extender (Minitub
GmBH, Landshut, Germany).  Frozen semen was thawed in a 37 C
water bath for 30 sec and treated as described in the “Sperm/DNA
incubation” section.  After incubation, an aliquot of sperm/DNA
incubation mix was diluted (without any selection process) in
Brackett-Oliphant (BO) medium [30] supplemented with 2.5 mM
caffeine (C4144), 10 IU/ml heparin (H3149) and 5 mg/ml fatty
acid-free bovine serum albumin (FAF-BSA) (A6003) at 20 × 106/
ml.  A sperm control group, without DNA incubation, was carried
out in parallel.  COCs were washed twice with BO medium con-
taining 5 mg/ml FAF-BSA and subsequently exposed to the sperm
suspension for 5 h in a 100 μl droplet at 39 C in a humidified atmo-
sphere of 6.5% CO2 in air.  Presumptive zygotes were then washed
tree times in TALP-H, and culture was continued as described
below.
Intracytoplasmic sperm injection (ICSI):  For ICSI, oocytes
were vortexed (to remove cumulus cells) for 2 min [1 mg/ml hyalu-
ronidase (H-4272) in DPBS] and washed tree times in HEPES-
buffered (H4034) TCM-199.  Mature oocytes were evaluated by
visualizing the first polar body and immediately used for ICSI.
Frozen semen were thawed in a 37 C water bath for 30 sec and sub-
jected to either the Long or Short Incubation described above.
After incubation, less than 0.05 μl of spermatozoa was transferred
to a 4-μl droplet of TALP-H with 10% v/v of polyvinylpyrrolidone
(PVP, 99219; Fisher Scientific, Pittsburgh, PA, USA) a used
directly for ICSI, which was performed as described previously
[25].  Briefly, the ICSI was performed in microdroplets of 20 μl of
TALP-H under mineral oil (M8410) in 100 × 20 mm tissue culture
dishes (430167; Corning, NY, USA) using Narishige hydraulic
micromanipulators (Medical Systems, Great Neck, NY, USA)
mounted on a Nikon Eclipse E-300 microscope (Nikon, Melville,
NY, USA).  Each selected spermatozoon was immobilized by
breaking its tail and aspirated tail-first into an 8-μm inner diameter
injection pipette.  The injection pipette was immediately passed
through a microdroplet of TALP-H to remove any attached sperma-
tozoa and then transferred to a droplet containing an oocyte.
Metaphase II oocytes were held under negative pressure in the
holding pipette, with the polar body at the 6 or 12 o’clock position.
The microinjection pipette was pushed through the zona pellucida
and into the cytoplasm of the oocyte at the 3 o'clock position.  Aspi-
ration was used to break the oolemma.  The spermatozoon and
aspirated ooplasm were then expelled into the oocyte with a mini-
mal volume (less than 10 pl) of PVP.  A sperm control group,
without DNA incubation, was carried out in parallel.
Oocyte chemical activation
Injected oocytes were immediately activated in TALP-H with 5
μM ionomycin (I24222; Invitrogen, Carlsbad, CA, USA) for 4 min
and placed in TCM-199 for 3 h to allow second polar body extru-
sion (except for Io-EtOH activation, where the 3-h window is not
necessary for polar body emission).  Oocytes were subsequently
treated with a) TCM-199 with 1.9 mM DMAP (D2629) for 3 h (Io-
DMAP Group); b) 5 μM ionomycin followed immediately by
TCM-199 with 1.9 mM DMAP for 3 h (2Io-DMAP Group); or c)
TALP-H with 7% (v/v) ethanol for 5 min (Io-EtOH Group).  In all
the cases, inhibitors were removed by washing three times in
TALP-H, and culture was continued as described below.
In vitro embryo culture
Presumptive IVF and ICSI zygotes (15–30 per group) were cul-
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tured in 50-μl droplets of SOF medium [31] containing 2.5% FBS
and incubated at 39 C in 6.5% CO2 in air.  Embryos were moved to
a new droplet every 48 h.  Cleavage was evaluated on day 2, and
the numbers of morulae and blastocysts were evaluated on day 7
postfertilization.
Evaluation of EGFP fluorescence in embryos
On day 7 postfertilization, all embryos recovered in vivo and
produced in vitro were briefly exposed to blue light using an exci-
tation filter at 488 nm and an emission filter at 530 nm to determine
egfp gene expression.
Sperm/exogenous DNA (eDNA) interaction
In order to analyze sperm/eDNA interaction, pCX-EGFP plas-
mid was labeled with Alexa fluor (F6257) by the Nick Translation
System (18160-010; Invitrogen).  Label eDNA was incubated in
accordance with the long and short treatments described above.
Afterwards, an aliquot of each labeled-DNA/spermatozoa complex
was diluted (10 μl in 90 μl of prewarmed TALP-H medium) and
centrifuged 5 min at 490 × g.  Then, the supernatant was removed
carefully, and the pellets were resuspended in 100 μl of TALP-H
(washing procedure).  Immediately, 10 μl of each sample (Fresh or
Frozen-Thawed and washed or non-washed spermatozoa) were
mounted between coverslips to observed under blue light the pres-
ence of label eDNA in sperm cells in order to distinguish between
motile and immotile ones.  Autoflorescence was discarded by
checking the spermatozoa before incubation treatments and after
unlabelled bovine genomic DNA fragment incubation treatments.
A second experiment was performed by labeling bovine genomic
DNA with rhodamine by the Nick Translation System (0.1 to 1 Kb
fragments) and using it for both sperm incubation treatments.  All
experiments were repeated at least two times using pooled semen
from two different rams.
Determination of sperm viability before and after exogenous 
DNA incubation 
Fresh semen (from two rams) that had been treated according to
the Long Incubation protocol were stained by incubation in TCM-
199 containing 1 mg/ml of Hoechst 33258 (861405) for 2 min, both
before and after pCX-EGFP addition.  Then, a 10-μl aliquot was
placed between coverslips to visualize spermatozoa.  At least 100
spermatozoa were observed under epifluorescent microscopy (UV
380) and classified as i) damaged membrane (stained sperm cells)
motile and immotile or ii) undamaged membrane (unstained sperm
cells) motile and immotile.  Control spermatozoa were coincubated
with Hoechst, but not with plasmid.
PCR analysis 
Morulae and blastocysts from LI, IVF and ICSI Short Incubation
with and without zonae pellucidae (ZPs) were washed in PBS,
transferred as 1-μl aliquots into an eppendorf tube, resuspended in
9 μl of extraction buffer (1 mg/ml proteinase K in 10 mM Tris–
EDTA, V302B, Promega, Madison, WI , USA) and incubated at 56
C for 1 h.  The samples were then heated at 95 C for 10 min, and 5-
μl aliquots were used for PCR.  The primer set sequences were 5–
GAAGTTCGAGGGCGACACCTG–3 and 5–TCGTCCATGC-
CGAGAGTGATC–3 for amplifying a 269 bp fragment of EGFP.
The PCR reaction conditions consisted of denaturation at 95 C for
2 min, followed by 35 amplification cycles of denaturation at 94 C
for 15 sec; annealing at 55 C for 15 sec and extension at 72 C for 25
sec.  Cycle 35 contained an additional extension at 72 C (7 min).
The positive control consisted of 3.6–11 g/ml of pCX-EGFP plas-
mid, and the negative control was distilled water.  The ZP was
removed by 5 min incubation in 1.5 mg/ml pronase (P8811) in
TALP-H, followed by careful washing five times in 3 ml of TALP-
H.
Determination of the cell number in blastocysts or spermatozoa 
bound to embryos
Embryos were stained (2 min) in TCM-199 containing 1 mg/ml
of Hoechst 33342 (B2261) and immediately mounted between cov-
erslips to visualize spermatozoa bound to the ZP (LI embryos) or to
count total nuclei (ICSI blastocysts) using epifluorescent micros-
copy (UV 380).
Fluorescence in situ hybridization (FISH)
Ovine 8-cell embryos were incubated for 20 h with 0.1 μg/ml
demecolcine (D1925).  Afterwards, the embryos were treated in a
hypotonic solution (1% Na citrate in distilled water for 10 min) and
fixed on a poly-L-lysine-coated slide with 3:1 methanol-acetic acid
solution.  Indirect labeled signals of FITC anti-mouse (F6257) and
anti-digoxigenin (D8156), which bind the digoxigenin-labeled
pCX-EGFP (5.5 kb) probe, were labeled using the Nick Translation
System (18160-010; Invitrogen).  The total DNA was counter-
stained with DAPI.  Images of each cell and their signals were
recorded with an Optronics camera (CCD; Optronics, Goleta, CA,
USA).
Data analysis
Embryo development and fluorescent expression were com-
pared by Fisher’s exact test analysis.  Differences in total cell
number or stained sperm were analyzed using a one-way ANOVA
test.  For statistical analyses, the SAS program was used [32].  Dif-
ferences were considered to be significant at P<0.05.
Results
Laparoscopic insemination, in vitro fertilization and 
intracytoplasmic sperm injection
A pool of semen collected from eight rams and incubated (long
or short treatment) with pCX-EGFP plasmid was used to insemi-
nate seventeen ewes.  After six days, LI embryos were recovered
through laparotomy and uterine flushing.  Fertilization rates were
not statistically different betweens Long and Short Incubation treat-
ments and the control group (90.4, 98.5 and 100% respectively).
None of the 78 collected embryos (38 and 40 for the long and short
procedures, respectively) were fluorescent after observation under
blue light (Table 1).
One hundred and sixty-two oocytes were fertilized by IVF with
spermatozoa previously incubated with pCX-EGFP plasmid in the
long or short treatments.  Plasmid incubation groups were not dif-
ferent from the controls in terms of cleavage (long, short and
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control: 86.8, 87.3 and 88.4%, respectively) or embryonic develop-
ment (Table 1).  Approximately 40% of the embryos reached the
morula and blastocyst stages.  Nevertheless, as in LI, no embryo
showed gfp expression under blue light (Table 1).
A total of 107 oocytes were injected with spermatozoa incubated
with pCX-EGFP plasmid.  Independent of incubation treatment,
high embryo development and transgene expression rates were
obtained (Table 1).  Although no differences were observed in
cleavage rates (long, short and control: 80.0, 79.2 and 86.3%,
respectively), a significant decrease in embryo development was
found after the ICSI Long Incubation treatment compared with the
Short Incubation treatment and control groups (P<0.05).  Further-
more, the short sperm/DNA incubation treatment showed the
highest percentage of exogenous gene-expressing embryos
(P<0.05).  Figure 1 shows three egfp-expressing blastocysts pro-
duced by the ICSI Short Incubation treatment.
Sperm/exogenous DNA interaction
Plasmid DNA attachment to the plasma membrane was observed
in most of the frozen-thawed spermatozoa subjected to the Long
and Short (Fig. 2A) Incubation treatments.  Nevertheless, sperm/
DNA cell complexes were quite labile, and specific fluorescence
signals disappeared after washing (Fig. 2A’).  Exogenous labeled-
DNA attachment was observed in all fresh spermatozoa from the
Long and Short (Fig. 2B) Incubation treatments.  However, in con-
trast to frozen-thawed spermatozoa, labeled DNA could not be
removed from nonmotile fresh spermatozoa by washing (Fig. 2B’).
The same patterns of interaction were observed with labeled bovine
genomic DNA fragments (Fig. 2C; 2C’).  No fluorescence signals
were detected in negative control groups, and no autofluorescence
was found in untreated sperm.
Determination of sperm viability before and after exogenous 
DNA incubation
The percentage of Fresh spermatozoa with a damaged mem-
brane did not differ before (33/110; 33.0%) or after pCX-EGFP
addition (43/110; 39.0%) for the Long Incubation treatment.  How-
ever, both results differed significantly with respect to the control
group (26/120, 21.6%; P<0.05).  All stained sperm cells (mem-
brane damaged) were immotile.
PCR analyses 
PCR analysis showed and egfp amplification product for LI
whole embryos (with a ZP).  Nevertheless, when LI embryos were
released from their ZPs by pronase treatment, no egfp PCR product
was visible in any of the embryos analyzed.  For IVF, no embryos
(with or without a ZP) showed PCR amplification products.  On the
other hand, all ICSI embryos showed amplification of the transgene
(Table 2).  We observed numerous spermatozoa (>25) adhered to
the ZP in stained recovered LI embryos (8/8).
In vitro development of transgenic-ICSI ovine embryos assisted 
by different chemical activation treatments
In total, 304 ovine oocytes were injected with spermatozoa incu-
bated with pCX-EGFP plasmid.  All ICSI activation protocols were
capable of producing blastocysts (Table 3).  The rate of blastocysts
and of egfp expressing-blastocysts (Green blastocysts) following
ICSI activation with 2Io-DMAP was not different from treatment
with Io-DMAP and Io-EtOH.  Transgene embryo expression rates
were not statistically different between groups.  Over 60% of blas-
tocysts expressed the transgene following the ICSI activation
treatments (Table 3).  We could not detect mosaicism at the blasto-
cyst stage, probably due to homogenous expression at that embryo
stage or intracellular protein migration.  Fluorescent (n=5) and non-
fluorescent (n=4) ICSI-derived blastocysts from the Io-DMAP acti-
vation protocol were selected and stained with Hoechst 33342 to
count the number of nuclei.  Mean cell numbers were not different
between the egfp-expressing and non-expressing blastocysts (61.6
± 14.0 vs. 70.3 ± 2.5; mean ± S.D.) respectively.
FISH analyses
FISH analysis displayed various possible integration loci in
eight of twelve (66.6%) ovine 8-cell stage embryos (Fig. 3).
Table 1. Development and transgenesis rates after laparoscopic insemination (LI), in vitro fertilization (IVF) and intracytoplasmic sperm
injection (ICSI) with semen previously incubated with pCX-EGFP plasmid in the ovine
  Incubation sperm/pCX-EGFP Technique Animals (n) Oocytes1 (n) Morulae and Green morulae and 
blastocysts (%) blastocysts (%)
  Long LI 9 42 38 (90.4)a 0 (0)a
IVF na 91 35 (38.4)bc 0 (0)a
ICSI na 25 6 (24.0)c 4/6 (66.6)b
  Short LI 8 44 40 (90.9)a 0 (0)a
IVF na 71 27 (38.0)bc 0 (0)a
ICSI na 82 36 (43.9)b 33/36 (91.6)c
  Control 2 LI 1 14 12 (85.7)a na
IVF na 69 35 (50.7)b na
ICSI na 44 20 (45.5)b na
na: Not applicable. 1 Total structure recovered. 2 Without sperm/DNA incubation. a, b and c Percentages within columns with different super-
scripts are statistically different (Fisher’s test; P<0.05).  Within each group, no significant differences were observed between replicates
(P>0.05, Fisher’s test).
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Fig. 1. EGFP-expressing embryos were produced by ICSI, injecting spermatozoa previously incubated with pCX-EGFP plasmid in
a Short Incubation treatment (5 min at 0–5 C). A: This figure shows three ovine blastocysts under bright light. B: The same
three blastocysts are shown under blue light (488 nm; original magnification, ×200).  The scale bars represent 100 μm.
Fig. 2. Frozen-thawed and fresh ovine sperm cells were incubated with
labeled plasmid or DNA fragments. Frozen-thawed labeled
spermatozoa showed fluorescence signals on the entire sperm
surface after a short exposure period (A, exposure 1/15) and did
not show signals after washing treatment (A’, exposure 1/4). In
contrast, fresh labeled spermatozoa showed fluorescence signals
after short procedure (B, exposure 1/4) and after washing
treatment only in nonmotile sperm cells (B’, exposure 1/4). Fresh
labeled rhodamine bovine spermatozoa after Short Incubation
(C, exposition 1/15) showed the same patterns of fluorescence
signals after a washing procedure (C’. exposure 1/15; original
magnification, ×1000).  The scale bars represent 10 μm.
Fig. 3. FISH analysis of ovine interphase eight-cell embryos with the
pCX-EGFP plasmid as a probe. The white arrows indicate
various signals compatible with various putative integration loci
(original magnification, ×1000).  The scale bar represents 5 μm.
Table 2. PCR analysis of laparoscopic insemination (LI), in vitro
fertilization (IVF) and intracitoplasmic sperm injection (ICSI)
in ovine embryos with or without a zona pellucida (ZP) 
GFP detection in embryos
Technique With ZP (n) Without ZP (n)
LI + (4/4) – (4/4)
IVF –  (10/10) – (10/10)
ICSI + (10/10) + (10/10)
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Discussion
After both the long and short sperm/exogenous DNA (eDNA)
incubation treatments, LI embryos did not express egfp transgene
(Table 1), even though seminal plasma was removed immediately
after semen collection and eight sperm donors were pooled in order
to minimize the “male factor” described in the porcine [28].  When
the long and short sperm/eDNA incubations were used in IVF,
spermatozoa were capable of fertilization, and the resulting
embryos developed as well as the controls.  However, no egfp-
expressing embryos were generated (Table 1).  These results agree
with previous reports for mice [12, 16].  In contrast, low production
of exogenous gene-expressing embryos has been reported in bovine
using different sperm/DNA incubation conditions [33].  In the
present study, exogenous gene-expressing embryos were always
obtained by ICSI after sperm/DNA incubation treatments.  During
Long Incubation, sperm cells are exposed to particular conditions
for a long period of time, which could induce apoptosis mecha-
nisms by active endonucleases into the spermatozoa [28], causing
lower rates of embryo development.  Embryos that express egfp
were generated after short exposure (Table 1) in greater percent-
ages that in previous reports [25].  A plausible explanation could be
that low temperatures of short sperm/DNA incubation enhance
DNA binding [34].
Several aspects of spermatozoa/DNA interaction were studied.
Both fresh and frozen/thawed spermatozoa bound eDNA, as has
been found in mice and some domestic species [35–37; for a
review, see 38].  Labeled DNA signals were detected on the sur-
faces of all fresh and frozen-thawed sperm after both treatments.
However, in agreement with observations in the bovine [39], only
nonmotile fresh spermatozoa maintained adhered eDNA after
washing (Fig. 2).  These results demonstrate a stronger interaction
between eDNA and nonmotile fresh spermatozoa than between
eDNA and motile fresh or frozen-thawed spermatozoa.  The revers-
ible interaction between eDNA and frozen-thawed sperm was
confirmed using washed frozen-thawed spermatozoa in ICSI,
where no egfp-expressing embryos were produced (n=30, data not
shown).  One difference between fresh and frozen-thawed sperma-
tozoa is the removal of seminal plasma from the former (see
Materials and Methods).  Some pioneer studies in pigs and mice
have demonstrated that elimination of seminal plasma is necessary
for a strong interaction between eDNA and sperm membranes [28,
36, 40].  On the other hand, when the sperm membrane integrity of
Fresh sperm cells incubated for a long time was analyzed, we
observed that all the nonmotile spermatozoa showed membrane
damage.  It has been reported that sperm membrane rupture
improves the binding of exogenous DNA to sperm [11].  In view of
these findings, absence of fluorescence in LI embryos could be
explained by the lack of motility of fresh sperm carrying eDNA.
On the other hand, the absence of fluorescence in embryos gener-
ated by IVF could be explained by the reversible interaction
between frozen-thawed sperm and eDNA detected in our study.
Consequently, we propose that during IVF, plasmid may be
removed from spermatozoa by dilution in IVF media or during
ooplasm penetration, as has been observed previously in monkeys
[41].  We consider that using fresh spermatozoa and solving the
lack of motility of sperm carrying eDNA are key factors for suc-
cessful SMGT by LI or IVF in the ovine.  Future research could
investigate changes in incubation conditions (shorter time or differ-
ent sperm/DNA exposure medium) and/or the addition of
liposomes [14, 42].  In contrast, ICSI bypasses the natural process
of gamete fusion and lack of sperm motility; therefore, the charac-
teristics described for sperm/DNA interactions are not an
impediment for the generation of egfp-expressing embryos by this
method of fertilization.
We saw that the fresh spermatozoa that maintained exogenous
attached DNA were nonmotile.  Unexpectedly, embryos produced
by LI (with fresh sperm) showed amplification of the transgene by
PCR analysis.  Nevertheless, when the PCR analysis was per-
formed on ZP-free embryos, we did not find a specific transgene
band.  In order to clarify these results, we stained LI embryos with
Hoechst.  We observed numerous spermatozoa adhered to the ZP in
100% of the stained recovered embryos, verifying that PCR ampli-
fication was derived from spermatozoa attached to the ZP and not
from the embryos.  This raised the question of how spermatozoa
carrying the transgene arrived at the ZP.  We propose two hypothe-
ses. 1) The first is that a small proportion of motile spermatozoa
carrying the transgene were able to reach the oocytes, but none of
them were able to fertilize it, and 2) the second is that nonmotile
spermatozoa carrying the transgene remained in the uterine horns
and could adhere to the ZP during embryo migration to the uterus.
The first hypothesis has been reported in pigs, where a low percent-
age of motile spermatozoa (1–3%) carried eDNA, although non
transgene-expressing-embryos were detected [43].  Perhaps differ-
ences in motility between sperm cells with and without attached
eDNA (membrane integrity) could explain the absence of trans-
gene-expressing embryos.  In our work, we have never seen an
ovine motile spermatozoon carrying label eDNA.  For this reason,
we are leaning towards the second hypothesis, although additional
studies should be done to confirm these hypotheses.  In the case of
PCR analyses of embryos produced by IVF and ICSI, the results
were negative and positive, respectively, and as it was expected,
Table 3. In vitro development and egfp-expression in ovine embryos produced by transgenic ICSI assisted by different protocols of chemical activation
Chemical activation No. of oocytes injected Cleaved (%) Green embryos (%) Morulae (%) Blastocysts (%) Green blastocysts (%)
Io + DMAP 106 78 (73.5)a 60 (56.6) 38 (35.8)a 14 (13.2) 12/14 (85.7)
2Io + DMAP 71 67 (94.3)b 33 (46.4) 24 (33.8)a 13 (18.3) 8/13 (61.5)
Io+ EtOH 127 114 (89.7)a,b 59 (46.4) 21 (16.5)b 18 (14.1) 12/18 (66.6)
Io, Ionomycin; DMAP, 6-Dimethylaminopurine; EtOH, Ethanol. a, b and c Percentages within columns with different superscripts are statistically different
(Fisher’s test; P<0.05). Within each group, no significant differences were observed between replicates (P>0.05, Fisher’s test).
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the results were independent of ZP presence.
The three different activation treatments evaluated induced blas-
tocyst development after ICSI.  In order to replace the activating
effect produced by piezoelectric microinjection [20], all treatments
in our work included an initial incubation in ionomycin.  The sec-
ond chemical stimuli by ethanol or ionomycin induced a longer
calcium peak, resembling the calcium behavior following conven-
tional fertilization [44].  The ICSI embryos activated with ethanol
were particularly interesting because, at least in the bovine, activa-
tion with DMAP in non-transgenic ICSI has been shown to result in
poor viability after transfer to recipient heifers in comparison with
ethanol activation [23, 24, 45].  Our results for exogenous gene-
expressing ICSI ovine blastocyst production are comparable and
even improved over previous reports of transgenic SCNT [5, 46] or
transgenic pronuclear microinjection [47].  Transgenic ICSI in the
ovine introduces an easy DNA construct delivery system and is
interesting for implementation in early reprograming events and
genetic therapy research.  On the other hand, the results obtained in
this work suggest that transgenic ICSI might be useful for large-
scale transgenic ovine offspring production.  In addition, in our
recent report in the bovine, ICSI-derived green embryos and blasto-
cysts showed normal parameters, cell numbers and Oct-4
expression that were indicative of normal embryonic development
[26].  The possibility of obtaining transgenic offspring by ICSI in
ruminants has been anticipated [48], but the absence of basic work
in this area has made it difficult to realize.  However, if necessary
transfer this embryos into the recipient ewes for confirm this
suggestions.
Simple PCR amplification or RT-PCR can be used to detect the
presence of a transgene, but they cannot determine its localization.
An alternative technique, fluorescent in situ hybridization (FISH),
can be used for this purpose.  For ICSI embryos, FISH analysis at
interphase found possible signals inside the nucleus compatible
with at least two or four integration loci (Fig. 3).  In mice and pigs,
there has been no discussion regarding the state of the transgene
after transgenic ICSI.  In both species, it has been demonstrated
that 5–25 transgene copies are integrated in one or two host
genome loci [11, 17].  Unfortunately, the size of transgene (5.5 kb)
and amount of DNA in a blastocyst (<6 pg) make it very difficult to
confirm transgene integration through techniques such as FISH or
Southern blot in our experience.  However, the results obtained in
our interphase FISH analysis confirm that sperm can import eDNA
into the nuclei of ICSI-derived ovine embryos and suggest that the
ICSI technique can be used in transgenic ovine production.
In conclusion, under the conditions studied, ICSI was the only
method of fertilization to successfully produce exogenous gene-
expressing ovine embryos, and the Short Incubation treatment
enhanced transgene expression percentages.  In addition, we found
it necessary to carefully remove the ZP from embryos in order to
avoid false positives by PCR.  To our knowledge, this is the first
study to explain possible failures involved in SMGT by LI or IVF
in the ovine.  The results obtained in this work demonstrated that
sperm-mediated gene transfer by ICSI could be useful for inducing
exogenous gene expression in ovine embryos.
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